Status:
COMPLETED
Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Chronic Renal Failure
Eligibility:
All Genders
Brief Summary
To evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Chronic renal failure patients with Hyperphosphatemia receiving peritoneal dialysis
Exclusion
Key Trial Info
Start Date :
March 19 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT01903213
Start Date
March 19 2013
End Date
December 31 2019
Last Update
October 22 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Chugoku, Japan
2
Chūbu, Japan
3
Hokkaido, Japan
4
Kansai, Japan